Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCSW) Non Operating Income (2021 - 2025)

Historic Non Operating Income for HeartSciences (HSCSW) over the last 5 years, with Q4 2025 value amounting to -$277366.0.

  • HeartSciences' Non Operating Income fell 18335.9% to -$277366.0 in Q4 2025 from the same period last year, while for Oct 2025 it was -$796992.0, marking a year-over-year decrease of 40216.87%. This contributed to the annual value of -$412658.0 for FY2025, which is 3781.08% down from last year.
  • Per HeartSciences' latest filing, its Non Operating Income stood at -$277366.0 for Q4 2025, which was down 18335.9% from -$180875.0 recorded in Q3 2025.
  • In the past 5 years, HeartSciences' Non Operating Income ranged from a high of $172595.0 in Q3 2021 and a low of -$277366.0 during Q4 2025
  • Its 5-year average for Non Operating Income is -$85029.1, with a median of -$87899.5 in 2021.
  • In the last 5 years, HeartSciences' Non Operating Income soared by 19977.45% in 2024 and then plummeted by 85433.73% in 2025.
  • Over the past 5 years, HeartSciences' Non Operating Income (Quarter) stood at -$77914.0 in 2021, then skyrocketed by 59.43% to -$31606.0 in 2022, then tumbled by 464.56% to -$178435.0 in 2023, then skyrocketed by 45.14% to -$97885.0 in 2024, then crashed by 183.36% to -$277366.0 in 2025.
  • Its Non Operating Income was -$277366.0 in Q4 2025, compared to -$180875.0 in Q3 2025 and -$173931.0 in Q2 2025.